Source study found

Story checked

Scientists Discover a Molecular “Memory” That Could Make Lost Weight Come Back (opens in a new tab)

scitechdaily.com · 2026-09-28

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

4 supported
2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

Scientists Discover a Molecular “Memory” That Could Make Lost Weight Come Back

scitechdaily.com · 2026-09-28

The story’s checkable claims.

Read the original story

NewsLink checks it

Mixed

Every claim we could check holds up. Four of six claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

4 supported
2 not covered

Open claim evidence

The source study

Adipose TGFβ-asprosin memory promotes obesity relapse and offspring obesity susceptibility

Cell Reports · 2026

Open source record Open in Tessa

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not coveredThe researchers say brief exposure to TGF-β1 caused a lasting epigenetic change that persisted for weeks after TGF-β1 levels normalized, and even after mice lost excess weight their fat cells continued producing more asprosin and sustaining appetite.View evidenceHide evidence

As statedfor weeks

Why this verdict

The core mechanism—transient TGF-β1 exposure remodeling chromatin at Fbn1, durable Fbn1/asprosin elevation after normalization/weight loss, and increased food intake—is supported at abstract level. However, the stated duration “for weeks” and details of how long the appetite/feeding effect persisted are not specified in the supplied abstract-depth profile, so that magnitude/timing cannot be verified here.

Study evidence

Exogenous TGF-β1 treatment of cultured adipocytes increases Fbn1 transcription and asprosin production.

“obesity-elevated cytokine TGF-β1 activates fibrillin-1 (Fbn1) transcription in adipocytes, increasing production of the appetite-stimulating hormone asprosin.”

Study evidence

Transient TGF-β1 exposure remodels chromatin at the Fbn1 locus in adipocytes, creating a durable transcriptional state associated with sustained Fbn1 expression and elevated circulating asprosin after washout/weight loss.

“Transient exposure to elevated TGF-β1 remodels chromatin at the Fbn1 locus, generating a durable transcriptional state …”

Claim 2 of 6Not coveredThe article says a separate laboratory independently confirmed that the cellular change persisted, and analyses of existing mouse and human datasets were consistent with the findings.View evidenceHide evidence

Why this verdict

The supplied abstract-depth profile does not include an independent-laboratory replication or analyses of existing mouse and human datasets. Those may be full-text or supplementary details, but they are not verifiable from the provided abstract-level evidence.

Claim 3 of 6SupportedResearchers say obesity may leave behind a cellular memory in fat cells that helps explain why lost weight often returns and why susceptibility can pass from mother to child.View evidenceHide evidence

Why this verdict

The abstract-level profile supports an adipose molecular/chromatin “memory” after obesity in mice, with persistent Fbn1/asprosin after weight loss, increased food intake/weight regain, and maternal TGF-β1 exposure increasing offspring diet-induced-obesity susceptibility. The claim is hedged as “may” and the story’s body notes mouse-dominant evidence, so the headline framing is broadly consistent, though its human-sounding phrasing depends on those caveats.

Study evidence

Transient obesity-elevated TGF-β1 induces chromatin remodeling at the adipocyte Fbn1 locus, producing a durable transcriptional state.

“… sustained Fbn1 expression and plasma asprosin elevation after weight loss and normalization of TGF-β1.”

Study evidence

Persistent elevation of circulating asprosin after prior obesity increases food intake in mice and promotes weight regain.

“In mouse models, this persistent asprosin elevation increases food intake, promoting weight regain.”

Claim 4 of 6SupportedThe study centers on asprosin, a hormone released by fat tissue that signals the brain to stimulate appetite; in mice, obesity altered fat-cell activity so that asprosin stayed elevated after weight loss.View evidenceHide evidence

Why this verdict

The profile identifies asprosin as an appetite-stimulating hormone produced via adipocyte Fbn1 and reports that in mouse obesity/weight-loss models adipose Fbn1 and circulating asprosin remain elevated after weight loss and TGF-β1 normalization. The link to increased food intake is also supported in mouse models.

Study evidence

Transient obesity-elevated TGF-β1 induces chromatin remodeling at the adipocyte Fbn1 locus, producing a durable transcriptional state.

“… sustained Fbn1 expression and plasma asprosin elevation after weight loss and normalization of TGF-β1.”

Study evidence

Persistent elevation of circulating asprosin after prior obesity increases food intake in mice and promotes weight regain.

“In mouse models, this persistent asprosin elevation increases food intake, promoting weight regain.”

Claim 5 of 6SupportedThe team reports that interfering with the pathway at several points, including the gene for asprosin or its brain receptor, prevented weight regain after dieting and prevented transmission of increased obesity susceptibility from mothers to offspring in mice.View evidenceHide evidence

Why this verdict

The profile states that genetic or pharmacologic disruption of the Fbn1–asprosin–Ptprd axis prevents post-weight-loss weight regain/increased food intake and prevents the maternal-programmed offspring susceptibility phenotype in mice. The abstract-level profile does not provide intervention specifics, but the story’s causal mouse claim matches the stated contribution.

Study evidence

Persistent elevation of circulating asprosin after prior obesity increases food intake in mice and promotes weight regain.

“In mouse models, this persistent asprosin elevation increases food intake, promoting weight regain.”

Study evidence

Maternal gestational exposure to elevated TGF-β1 results in persistent elevation of Fbn1 expression in offspring adipose tissue.

“maternal TGF-β1 exposure during gestation programs offspring adipose tissue, leading to persistent Fbn1 expression, elevated plasma asprosin, and increased susceptibility to diet-induced obesity.”

Claim 6 of 6SupportedThe story emphasizes that the work is mainly in mice and says researchers still need to establish whether human fat cells retain the same epigenetic memory after weight loss and how strongly asprosin affects long-term weight outcomes in people.View evidenceHide evidence

Why this verdict

The profile’s experimental units are in vitro adipocyte studies and in vivo mouse studies, and multiple limitations note that generalizability to humans is not established from the abstract-level evidence. The story’s caveat that direct human confirmation and long-term human outcome relevance remain to be tested is consistent with the profile.

Study evidence

Exogenous TGF-β1 treatment of cultured adipocytes increases Fbn1 transcription and asprosin production.

“obesity-elevated cytokine TGF-β1 activates fibrillin-1 (Fbn1) transcription in adipocytes, increasing production of the appetite-stimulating hormone asprosin.”

Study evidence

“Transient exposure to elevated TGF-β1 remodels chromatin at the Fbn1 locus, generating a durable transcriptional state …”

Then look for missing context

Context layer

What the story carried across

Nothing material from the study was dropped.

5 things the story did carry across

Obesity-elevated TGF-β1 induces durable adipocyte chromatin/transcriptional remodeling at the Fbn1 locus, sustaining Fbn1/asprosin after weight loss.
Persistent asprosin elevation after prior obesity increases food intake and promotes post-weight-loss weight regain in mouse models.
Maternal TGF-β1 exposure during gestation programs offspring adipose Fbn1/asprosin elevation and increases offspring susceptibility to diet-induced obesity in mice.
Genetic or pharmacologic disruption of the Fbn1–asprosin–Ptprd axis prevents both obesity relapse and offspring susceptibility phenotypes in mouse models.
Most direct experimental evidence in the profile is from mice or in vitro adipocyte systems, not direct human intervention or longitudinal human weight-loss evidence.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

in vivo animal

1Lead resultin vivo animalObesity-elevated TGF-β1 induces durable adipocyte chromatin/transcriptional remodeling at the Fbn1 locus that sustains Fbn1 expression and circulating asprosin even after weight loss (an adipose “memory” state).in vivo mouse diet-induced obesity and weight-loss paradigmExpand

In plain English

In mouse diet-induced obesity models, transiently elevated adipose TGF-β1 drives increased transcription of Fbn1 in adipocytes and higher circulating asprosin; chromatin remodeling at the Fbn1 locus after TGF-β1 exposure produces a durable transcriptional state such that adipose Fbn1 expression and plasma asprosin remain elevated after weight loss and normalization of TGF-β1.

Key findings

Transient obesity-elevated TGF-β1 induces chromatin remodeling at the adipocyte Fbn1 locus, producing a durable transcriptional state.
Sustained Fbn1 expression after weight loss is associated with persistently elevated circulating asprosin, despite normalization of TGF-β1 and body weight.

“… sustained Fbn1 expression and plasma asprosin elevation after weight loss and normalization of TGF-β1.”

What this piece can’t prove

Summary and claims are drawn from the paper abstract; the abstract does not report quantitative effect sizes, durations of persistence, sample sizes, or statistical details.

2 further details could not be confirmed from the summary.

2in vitroObesity-elevated TGF-β1 induces durable adipocyte chromatin/transcriptional remodeling at the Fbn1 locus that sustains Fbn1 expression and circulating asprosin even after weight loss (an adipose “memory” state).in vitro transient TGF-β1 exposure with washoutExpand

In plain English

In cultured adipocytes, exogenous TGF-β1 induces Fbn1 transcription and increases asprosin production; transient TGF-β1 exposure followed by washout remodels chromatin at the Fbn1 locus and produces a durable transcriptional state with sustained Fbn1 expression and continued asprosin output after TGF-β1 normalization.

Key findings

Exogenous TGF-β1 treatment of cultured adipocytes increases Fbn1 transcription and asprosin production.
A transient TGF-β1 exposure induces chromatin remodeling at the Fbn1 locus that is associated with a durable transcriptional state: after washout/normalization of TGF-β1, cultured adipocytes maintain elevated Fbn1 expression and continued asprosin output.

“obesity-elevated cytokine TGF-β1 activates fibrillin-1 (Fbn1) transcription in adipocytes, increasing production of the appetite-stimulating hormone asprosin.”

What this piece can’t prove

In vitro adipocyte experiments may not capture contributions from systemic, cell–cell, or tissue-level contexts present in vivo.

1 further detail could not be confirmed from the summary.

3in vitroObesity-elevated TGF-β1 induces durable adipocyte chromatin/transcriptional remodeling at the Fbn1 locus that sustains Fbn1 expression and circulating asprosin even after weight loss (an adipose “memory” state).In vitro locus-focused epigenomic/chromatin assays with time-course (transient TGF-β1 exposure and washout)Expand

In plain English

In adipocytes, transient exposure to elevated TGF-β1 remodels chromatin at the Fbn1 locus, producing a durable transcriptional state that sustains Fbn1 expression and elevated circulating asprosin after normalization/washout (described by the authors as an adipose “memory” of prior obesity). Chromatin-level evidence was generated by locus-focused epigenomic/chromatin assays with time-course/persistence assessment comparing post-exposure (washout/normalization) states to pre-exposure baselines.

Key findings

Transient TGF-β1 exposure remodels chromatin at the Fbn1 locus in adipocytes, creating a durable transcriptional state associated with sustained Fbn1 expression and elevated circulating asprosin after washout/weight loss.

“Transient exposure to elevated TGF-β1 remodels chromatin at the Fbn1 locus, generating a durable transcriptional state …”

What this piece can’t prove

Unit is based on locus-focused chromatin assays described in the paper; absence of detailed method-level parameters (assay type, replicates, normalization, peak calling) in this summary limits assessment of technical robustness.
Findings summarized here are from in vitro adipocyte settings per the method profile; applicability to whole-tissue in vivo chromatin states depends on complementary in vivo data.

1 further detail could not be confirmed from the summary.

4in vivo animalPersistent asprosin elevation after prior obesity increases food intake and promotes weight regain (obesity relapse) in mice.in vivo mouse weight regainExpand

In plain English

In mouse models, persistent elevation of circulating asprosin after prior obesity/weight loss is reported to increase food intake and promote weight regain; this phenotype is linked to sustained Fbn1 expression in adipose tissue and is preventable by disrupting the Fbn1-asprosin-Ptprd axis.

Key findings

Persistent elevation of circulating asprosin after prior obesity increases food intake in mice and promotes weight regain.
Genetic or pharmacologic disruption of the Fbn1-asprosin-Ptprd axis prevents the increased food intake and weight regain associated with persistent asprosin elevation.

“In mouse models, this persistent asprosin elevation increases food intake, promoting weight regain.”

What this piece can’t prove

3 further details could not be confirmed from the summary.

5in vivo animalMaternal TGF-β1 exposure during gestation programs offspring adipose tissue to maintain elevated Fbn1/asprosin and increases susceptibility to diet-induced obesity (intergenerational risk).mouse gestational exposure modelExpand

In plain English

In a mouse gestational exposure model, transient maternal exposure to elevated TGF-β1 during pregnancy programs offspring adipose tissue to maintain elevated Fbn1 expression and plasma asprosin and increases offspring susceptibility to diet-induced obesity. The paper reports that genetic or pharmacologic disruption of the Fbn1–asprosin–Ptprd axis prevents these outcomes.

Key findings

Maternal gestational exposure to elevated TGF-β1 results in persistent elevation of Fbn1 expression in offspring adipose tissue.
Offspring from TGF-β1–exposed dams have elevated plasma asprosin.

“maternal TGF-β1 exposure during gestation programs offspring adipose tissue, leading to persistent Fbn1 expression, elevated plasma asprosin, and increased susceptibility to diet-induced obesity.”

What this piece can’t prove

Details of the diet-induced obesity challenge protocol (composition, duration, age at challenge) are not provided.

4 further details could not be confirmed from the summary.

6in vivo animalDisruption of the Fbn1–asprosin–Ptprd axis (genetic or pharmacologic) prevents obesity relapse and offspring susceptibility phenotypes, supporting pathway necessity/therapeutic tractability.In vivo mouse genetic and pharmacologic interventionsExpand

In plain English

In mouse models, genetic or pharmacologic disruption of the adipose Fbn1–asprosin–Ptprd axis prevented both (a) post-weight-loss weight regain (increased food intake/relapse) and (b) increased offspring obesity susceptibility associated with maternal TGF-β1 exposure, implicating the axis as necessary for these phenotypes and as a potential therapeutic target.

Key findings

Genetic or pharmacologic disruption of the Fbn1–asprosin–Ptprd axis prevents post-weight-loss weight regain and prevents the maternal-programmed increase in offspring obesity susceptibility.

“Finally, genetic or pharmacologic disruption of the Fbn1-asprosin-Ptprd axis prevents both phenomena.”

What this piece can’t prove

Summary is based on abstract statements; the abstract does not include experimental detail (sample sizes, statistical significance, exact interventions, or controls).
Unclear whether interventions were performed in the same or separate cohorts for relapse versus offspring phenotypes and whether experiments were randomized/blinded.

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer